Showing results (71-80 of 127) with videos related to

Sort By:
Pageof 13
Scientific Reports|October 22, 2024
Matched three-dimensional organoids and two-dimensional cell lines of melanoma brain metastases mirror response to targeted molecular therapyWilliam H Hicks, Lauren C Gattie, Mohamad El Shami, et al.
Frontiers in Neurology|September 26, 2019
A Novel TTC19 Mutation in a Patient With Neurological, Psychological, and Gastrointestinal ImpairmentParham Habibzadeh, Soroor Inaloo, Mohammad Silawi, et al.
BMC Medical Genetics|February 5, 2020
Pre-implantation genetic diagnosis in an Iranian family with a novel mutation in MUT geneParham Habibzadeh, Zahra Tabatabaei, Mohammad Ali Farazi Fard, et al.
Journal for Immunotherapy of Cancer|August 14, 2024
Case report of fatal immune-mediated myocarditis following treatment with davoceticept (ALPN-202), a PD-L1-dependent CD28 costimulator and dual PD-L1/CTLA-4 checkpoint inhibitor, in combination with pembrolizumabLudimila Cavalcante, Sreenivasa Chandana, Nehal Lakhani, et al.
Frontiers in Oncology|December 13, 2021
Immune-Related Adverse Events in PD-1 Treated Melanoma and Impact Upon Anti-Tumor Efficacy: A Real World AnalysisMelissa L Bastacky, Hong Wang, Dylan Fortman, et al.
Acta Biomaterialia|February 18, 2025
Subcutaneous liposomal delivery improves monoclonal antibody pharmacokinetics in vivoMaryam Karimi, Arash Aslanabadi, Ben Atkinson, et al.
Frontiers in Oncology|July 3, 2023
Metformin is associated with improved clinical outcomes in patients with melanoma: a retrospective, multi-institutional studyRyan C Augustin, Ziyu Huang, Fei Ding, et al.
JCI Insight|July 27, 2018
CD226 opposes TIGIT to disrupt Tregs in melanomaJulien Fourcade, Zhaojun Sun, Joe-Marc Chauvin, et al.
Medrxiv : the Preprint Server for Health Sciences|November 24, 2025
Multiregional CT Features Improve Prediction of Immunotherapy Response in Advanced MelanomaGrant Kokenberger, Jatin Singh, Drew Hurd, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 24, 2025
Combined Targeting of PD-1 and TIM-3 in Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer: AMBER Part 2BDiwakar Davar, Zeynep Eroglu, Mohammed Milhem, et al.
Pageof 13